Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2026
Interrelationship of Tissue Factor With Thromboinflammatory Biomarkers in ESRD and CKD 5 Patients.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rohde Luke, Siddiqui Fakiha, Konczak Katherine, Kaufmann Ella, Hoppensteadt Debra, Walenga Jeanine, Bansal Vinod, Hussain Hamzah, Fareed Jawed, Vellanki Kavitha
Аннотация
Chronic kidney disease (CKD) affects hundreds of millions worldwide and contributes to significant morbidity and mortality. Understanding its pathophysiology may help identify plasma biomarkers that reflect disease severity and treatment response. This study compared plasma tissue factor (TF) concentrations between end-stage renal disease (ESRD) patients and healthy controls using combined 2022 and 2023 retrospective cohorts (142 ESRD, 22 controls). Mean TF levels were calculated, and percent change for each ESRD patient was determined relative to the healthy control mean. In 2022, normal human plasma (NHP) TF averaged 96.37 ± 12.72 pg/mL versus 305.19 ± 11.57 pg/mL in ESRD patients, a 216.68% increase. In 2023, NHP TF was 60.19 ± 12.12 pg/mL compared with 341.93 ± 20.40 pg/mL in ESRD patients, a 468.11% increase. Across both cohorts, ESRD patients showed markedly elevated TF levels, supporting a pronounced pro-thrombotic state driven by inflammation and endothelial dysfunction from chronic uremic metabolite accumulation.